Robust Escalation of Nicotine Intake with Extended Access to Nicotine Self-Administration and Intermittent Periods of Abstinence (original) (raw)
Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science282: 298–300. ArticleCASPubMed Google Scholar
Ahmed SH, Walker JR, Koob GF (2000). Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology22: 413–421. CASPubMed Google Scholar
Ben-Shahar O, Ahmed SH, Koob GF, Ettenberg A (2004). The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res995: 46–54. ArticleCASPubMed Google Scholar
Berlin I, Anthenelli RM (2001). Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol4: 33–42. ArticleCASPubMed Google Scholar
Conklin CA, Perkins KA, Sheidow AJ, Jones BL, Levine MD, Marcus MD (2005). The return to smoking: 1-year relapse trajectories among female smokers. Nicotine Tob Res7: 533–540. ArticlePubMed Google Scholar
Cummings KM, Mahoney M (2006). Current and emerging treatment approaches for tobacco dependence. Curr Oncol Rep8: 475–483. ArticlePubMed Google Scholar
Doubeni CA, Reed G, Difranza JR (2010). Early course of nicotine dependence in adolescent smokers. Pediatrics125: 1127–1133. ArticlePubMed Google Scholar
Dougherty J, Miller D, Todd G, Kostenbauder HB (1981). Reinforcing and other behavioral effects of nicotine. Neurosci Biobehav Rev5: 487–495. ArticleCASPubMed Google Scholar
Engelmann JM, Radke AK, Gewirtz JC (2009). Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats. Psychopharmacology (Berl)207: 13–25. ArticleCAS Google Scholar
Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature393: 76–79. ArticleCASPubMed Google Scholar
Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W et al (2003). Low monoamine oxidase B in peripheral organs in smokers. Proc Natl Acad Sci USA100: 11600–11605. ArticleCASPubMedPubMed Central Google Scholar
Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R et al (1996). Inhibition of monoamine oxidase B in the brains of smokers. Nature379: 733–736. ArticleCASPubMed Google Scholar
George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH et al (2007). CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci USA104: 17198–17203. ArticleCASPubMedPubMed Central Google Scholar
Greenwell TN, Funk CK, Cottone P, Richardson HN, Chen SA, Rice KC et al (2009). Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long-, but not short-access rats. Addict Biol14: 130–143. ArticleCASPubMedPubMed Central Google Scholar
Grunberg NE (1994). Overview: biological processes relevant to drugs of dependence. Addiction89: 1443–1446. ArticleCASPubMed Google Scholar
Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M et al (2005). Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci25: 8593–8600. ArticleCASPubMedPubMed Central Google Scholar
Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M et al (2006). Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci24: 3532–3540. ArticlePubMed Google Scholar
Henningfield JE, Goldberg SR (1983). Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav19: 989–992. ArticleCASPubMed Google Scholar
Hughes JR, Higgins ST, Bickel WK (1994). Nicotine withdrawal vs other drug withdrawal syndromes: similarities and dissimilarities. Addiction89: 1461–1470. ArticleCASPubMed Google Scholar
Irvine EE, Cheeta S, File SE (2001). Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav68: 319–325. ArticleCASPubMed Google Scholar
Jarvik ME, Madsen DC, Olmstead RE, Iwamoto-Schaap PN, Elins JL, Benowitz NL (2000). Nicotine blood levels and sublective craving for cigarettes. Pharmacol Biochem Behav66: 553–558. ArticleCASPubMed Google Scholar
Kapelewski CH, Vandenbergh DJ, Klein LC (2011). Effect of the monoamine oxidase inhibition on rewarding effects of nicotine in rodents. Curr Drug Abuse Rev4: 110–121. ArticleCASPubMed Google Scholar
Kenny PJ, Markou A (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology31: 1203–1211. ArticleCASPubMed Google Scholar
Kim MJ, Fleming CB, Catalano RF (2009). Individual and social influences on progression to daily smoking during adolescence. Pediatrics124: 895–902. ArticlePubMed Google Scholar
Kitamura O, Wee S, Specio SE, Koob GF, Pulvirenti L (2006). Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl)186: 48–53. ArticleCAS Google Scholar
Koob GF (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res1314: 3–14. ArticleCASPubMed Google Scholar
Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology24: 97–129. ArticleCASPubMed Google Scholar
Kozlowski LT, Wilkinson DA, Skinner W, Kent C, Franklin T, Pope M (1989). Comparing tobacco cigarette dependence with other drug dependencies: greater or equal ‘difficulty quitting’ and ‘urges to use,’ but less ‘pleasure’ from cigarettes. JAMA261: 898–901. ArticleCASPubMed Google Scholar
LeSage MG, Burroughs D, Pentel PR (2006). Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. Pharmacol Biochem Behav83: 585–591. ArticleCASPubMed Google Scholar
Lotfipour S, Arnold MM, Hogenkamp DJ, Gee KW, Belluzzi JD, Leslie FM (2011). The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology61: 95–104. ArticleCASPubMedPubMed Central Google Scholar
Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA et al (1992). Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav43: 779–784. ArticleCASPubMed Google Scholar
McManus DJ, Greenshaw AJ (1991). Differential effects of antidepressants on GABAB and _β_-adrenergic receptors in rat cerebral cortex. Biochem Pharmacol42: 1525–1528. ArticleCASPubMed Google Scholar
O’Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE et al (2007). Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther320: 180–193. ArticlePubMed Google Scholar
O’Dell LE, Koob GF (2007). ‘Nicotine deprivation effect’ in rats with intermittent 23-hour access to intravenous nicotine self-administration. Pharmacol Biochem Behav86: 346–353. ArticlePubMedPubMed Central Google Scholar
Paterson NE, Markou A (2004). Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology (Berl)173: 64–72. ArticleCAS Google Scholar
Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C, Doll R (1996). Mortality from smoking worldwide. Br Med Bull52: 12–21. ArticleCASPubMed Google Scholar
Pomerleau CS, Pomerleau OF (1992). Euphoriant effects of nicotine in smokers. Psychopharmacology (Berl)108: 460–465. ArticleCAS Google Scholar
Richardson NR, Roberts DCS (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods66: 1–11. ArticleCASPubMed Google Scholar
Risner ME, Goldberg SR (1983). A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther224: 319–326. CASPubMed Google Scholar
Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R et al (2008). Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol Clin Exp Res32: 1816–1823. ArticleCASPubMedPubMed Central Google Scholar
Solomon RL, Corbit JD (1973). An opponent-process theory of motivation: II. Cigarette addiction. J Abnorm Psychol81: 158–171. ArticleCASPubMed Google Scholar
Stolerman IP, Jarvis MJ (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl)117: 2–10; discussion, 14–20. ArticleCAS Google Scholar
Torrijos RM, Glantz SA (2006). The US Public Health Service ‘treating tobacco use and dependence clinical practice guidelines’ as a legal standard of care. Tob Control15: 447–451. ArticlePubMedPubMed Central Google Scholar
US Department of Health and Human Services (1988). The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General, 1988 (DHHS Publication no. [CDC] 88-8406). Centers for Disease Control and Prevention, Office on Smoking and Health: Rockville.
Valentine JD, Hokanson JS, Matta SG, Sharp BM (1997). Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl)133: 300–304. ArticleCAS Google Scholar
Villégier AS, Blanc G, Glowinski J, Tassin JP (2003). Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav76: 267–274. ArticlePubMed Google Scholar
Villégier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM et al (2006). Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology31: 1704–1713. ArticlePubMed Google Scholar